HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tetrabenazine for involuntary movement disorders.

Abstract
The use of tetrabenazine to treat the movement disorder of Huntington's chorea and other dyskinesias is described. Tetrabenazine produced moderate to marked improvement in the movement disorder in 79% of a series of 40 Australian patients. The most commonly reported side effects were depression, drowsiness and Parkinsonism.
AuthorsD Kingston
JournalThe Medical journal of Australia (Med J Aust) Vol. 1 Issue 13 Pg. 628-30 (Jun 30 1979) ISSN: 0025-729X [Print] Australia
PMID158700 (Publication Type: Journal Article)
Chemical References
  • Tetrabenazine
Topics
  • Humans
  • Huntington Disease (drug therapy)
  • Middle Aged
  • Movement Disorders (drug therapy)
  • Tetrabenazine (adverse effects, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: